September 29, 2026

Clover Health Investments (CLOV): Exploring a 24% Upside Potential with a Strong Revenue Growth Story

Clover Health Investments, Corp. (NASDAQ: CLOV) stands as a noteworthy player in the healthcare sector, specifically within the healthcare plans industry. With a strong focus on..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 66% ROE and Promising Analyst Ratings

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) stands out in the biotechnology sector with its focus on developing therapies for autoimmune diseases with significant unmet needs. Headquartered in..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A Promising 19.93% Upside in the Booming Mental Health Sector

Investors eyeing opportunities in the healthcare sector might find LifeStance Health Group, Inc. (NASDAQ: LFST) an intriguing candidate. With a market capitalization of $4.5 billion, LifeStance..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Evaluating a Potential 89% Upside in Biotech Innovation

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology sector, has been capturing attention with its innovative approach to tackling cardiorenal conditions. As a..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Exploring a 32.86% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a leading player in the development and sale of buprenorphine-based prescription drugs, has been drawing attention from investors due to its..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 2.92% Upside

Azenta, Inc. (NASDAQ: AZTA) presents a compelling opportunity for investors looking to capitalize on steady growth within the healthcare sector. Specializing in medical instruments and supplies,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unpacking a 12.67% Upside Potential for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, particularly in the medical care facilities industry, has captured the attention of investors..

agilon health, inc. (AGL) Stock Analysis: Navigating a 48.79% Upside Potential in Healthcare

Investors with a keen eye on the healthcare sector may find agilon health, inc. (NYSE: AGL) a compelling opportunity, as the company navigates the complex landscape..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 49.65% Potential Upside Driven by Innovative Immunotherapies

ImmunityBio, Inc. (NASDAQ: IBRX) stands at the intersection of biotechnology innovation and investor interest, with a market cap of $9.03 billion. This San Diego-based company operates..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the Potential Despite a -33.56% Downside Projection

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, has carved out a significant niche in the medical devices industry. Specializing in cutting-edge..

Apogee Therapeutics (APGE): Investor Outlook on a $10.22 Billion Biotech Pioneer

In the dynamic world of biotechnology, Apogee Therapeutics, Inc. (NASDAQ: APGE) stands out as a formidable player, with an impressive market capitalization of $10.22 billion. Based..

Ocular Therapeutix (OCUL): Investor Outlook Reveals 253.90% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing the attention of investors with its promising pipeline in the biotechnology sector. Specializing in innovative ophthalmic therapies, this Bedford,..

Astrana Health Inc. (ASTH) Stock Analysis: Strong Buy Ratings Signal 47% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company, is capturing investor attention with its impressive growth metrics and a strong buy consensus from analysts. Based..

Envista Holdings Corporation (NVST) Stock Analysis: A 26.42% Potential Upside in the Dental Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) is a key player in the healthcare sector, specializing in medical instruments and supplies, particularly in the dental industry. With a..

CG Oncology, Inc. (CGON) Stock Analysis: Navigating a 30.84% Potential Upside in the Biotechnology Sector

In the rapidly evolving landscape of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) stands out as a noteworthy player, attracting significant attention from investors due to its..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Strong Buy Ratings and 22% Upside Potential

Investors in the biotech space are closely monitoring Travere Therapeutics, Inc. (NASDAQ: TVTX), a company that has carved a niche in addressing rare kidney and metabolic..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking a 61.87% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) is standing at an intriguing juncture for biotechnology investors. With a significant market capitalization of $5.23 billion, this Switzerland-based company is..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Uncovering a Potential 201% Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is a name that has been catching the eye of investors in the healthcare sector, particularly those focusing on biotechnology. With..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a Remarkable 180% Potential Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing opportunity for investors searching for growth in the healthcare sector. With a market capitalization of $1.64 billion, Alignment..

Schrodinger, Inc. (SDGR) Stock Analysis: Unpacking Potential in Health Information Services Amid Market Challenges

Schrodinger, Inc. (NASDAQ: SDGR) presents a compelling case for investors navigating the healthcare sector, particularly within the niche of health information services. The company, with a..

Search

Funds

September 29, 2026

Search

Funds

September 29, 2026

FTSE 100

Funds